Carolinas HealthCare System

Research and Clinical Trials

Title  
STRIIVING (ViiV Healthcare 201147
Brief Description  
To determine the safety and efficacy of an experimental drug, abacavir/dolutegravir/lamivudine (ABC/DTG/3TC) fixed dose combination as a single tablet regimen compared with subjects taking their current combined antiretroviral therapy (cART) for the treatment of HIV-1 infected adults in whome the HIV-1 virus is currently suppressed.
Who may be Eligible  
Adults aged 18 or older; Agree not to become pregnant or father a child during the study term; Have an HIV viral load <50 for past 2 visits; Have been on current regimen for >6 months; Have stable maintenance labs; Not be on Dolutegravir (Tivicay) or Etravirine (Intelence); Normal EKG
Specialty/Disorder  
HIV
Start Date  
08/01/2014
IRB Number  
C-185
Principal Investigator  
Johnson, Marc
Contact Name  
Jessica

For More Information, Contact   Jessica  A.  Kearney-Bryan , BSN
Phone:  (704) 355-0244  Fax:  (704) 446-7641 
Email:  Jessica.Kearney-bryan@carolinas.org
Address:  3rd Floor Myer's Park Clinic
1350 S. Kings Drive
Charlotte, NC 28207
Close